The Influence of Gender on Dual Task Performance in Young Healthy Adults

Status Recruiting

Clinical Trial Summary

Dual tasking (DT), or the act of conducting multiple, simultaneous tasks, is wide spread in daily life .In particular, the vast majority of mobility tasks we complete (e.g., standing, walking, stepping, etc.) occur while distracted by another motor and/or cognitive task. A common feature of DT is that performance on one or both tasks is diminished when completed together .Understanding the relationship between gender and dual task performance is important because this knowledge could help inform us the development of interventions or training programs that target these differences and improve overall performance. Aims: To investigate the gender-related differences in single task performance through motor torque, cognitive tasks and walking speed, and the combined dual-task costs considering both motor and cognitive performance in a sample of young adults

Clinical Trial Description

gender differences on dual task performance in young healthy adults. Dual task performance refers to the ability of an individual to perform two tasks simultaneously, which can be a challenging cognitive task because the human brain has a limited capacity for attention and processing. When an individual attempts to perform two tasks at once, they must divide their attention and resources between the two tasks, which can lead to decreased performance and increased errors. The study will evaluate motor performance, muscle force production, and average speed through a walking test. Sixty non-athlete participants (30 female and 30 male) will be recruited, and ANCOVA will be used for statistical analysis.The participants will perform the following tasks: single mobility tasks (average speed through walking test for 45 seconds), single muscle force production, single cognitive task, dual-task condition: walking test and cognitive task, and dual-task condition: muscle torque test and cognitive task ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05912530
Study type	Observational [Patient Registry]
Source	Jouf University
Contact	Radwa Talaat Elshorbagy, Assistant professor
Phone	00966500920691
Email	Rtelshorbagy@ju.edu.sa
Status	Recruiting
Phase
Start date	June 30, 2023
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05712005` - Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
Completed	`NCT05343208` - Effectiveness of Online Therapy to Prevent Burnout	N/A
Active, not recruiting	`NCT05143294` - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT05267730` - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT03987477` - Online Intervention to Modify Interpretation Biases in Depression	N/A
Completed	`NCT03695003` - Cognitive Effects of Sage in Healthy Humans	N/A
Completed	`NCT05075850` - Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
Recruiting	`NCT05273996` - Predictors of Cognitive Outcomes in Geriatric Depression	Phase 4
Completed	`NCT03674281` - The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System	N/A
Completed	`NCT03689348` - Acute and Chronic Effects of Avena Sativa on Cognition and Stress	N/A
Active, not recruiting	`NCT05229705` - Exercise in Older Adults at Risk for Type 2 Diabetes	N/A
Suspended	`NCT05001789` - Cognitive Functioning in Opioid Use Disorder	N/A
Terminated	`NCT03337282` - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Recruiting	`NCT05014399` - Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Completed	`NCT03657537` - Effects of Ketone Bodies on Cognition in Type 2 Diabetes	Phase 1
Completed	`NCT05543811` - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology	N/A
Recruiting	`NCT05699226` - Amplitude Titration to Improve ECT Clinical Outcomes	N/A
Recruiting	`NCT05026541` - Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators	N/A
Active, not recruiting	`NCT03255499` - Efficacy of the MovinCog Intervention in Children	N/A
Not yet recruiting	`NCT06252376` - Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.